Abingdon Health Plc (AIM:ABDX) acquired Ivdeology Holdings Ltd for £0.7 million on May 7, 2024.The consideration consists of £0.5 million in common equity and an earn-out of £0.2 million. Any consideration due under the Earn-out will be satisfied in Ordinary Shares to the current owners of IVDeology. These additional shares will be subject to a further 12-month lock-in agreement followed by orderly market provisions. Application has been made for the admission to trading on AIM for the 5 million new Initial Consideration shares ("Admission"). It is expected that Admission will become effective on 10 May 2024. Following the issue of the 5 million new Initial Consideration shares the Company will have a total of 126,716,822 Ordinary Shares in issue. In its financial year ending 31 January 2024, IVDeology generated turnover of £0.392 million and net assets of £0.043 million.

Abingdon Health Plc (AIM:ABDX) completed the acquisition of Ivdeology Holdings Ltd for £0.7 million on May 7, 2024.